The Alexander Group proudly announces Leah Salinas has joined the firm as a Director in its Houston office. Salinas’ clients include a broad range of middle-market companies, and private equity and venture capital firms. 

“Leah’s record of helping clients build impactful executive management teams—particularly in the energy sector—is a terrific fit for us,” said Amanda Brady, Managing Director of The Alexander Group. “We are delighted to welcome her to our team.”

Salinas has extensive experience recruiting energy executives for leadership roles, with an emphasis on midstream, transition, and carbon capture, and also for the industrial, manufacturing, distribution, technology, and construction sectors.

“I am thrilled to join The Alexander Group, with its 40 year history, a global presence, and outstanding reputation.  The firm’s client-first commitment, coupled with its research-intensive approach, gives it a competitive edge and makes it an exceptional home  for long-lasting client relationships,” Salinas said.

Allison Rosenthal has joined Lykos Therapeutics as the company’s first Chief Commercial Officer. Ms. Rosenthal leads Lykos’ trailblazing commercial strategy and operations, initially focusing on the potential launch of MDMA-assisted therapy for their lead program to treat those suffering with PTSD. If approved by the FDA, anticipated in Q3 of 2024, this will be the first psychedelic-assisted therapy approved for medical use.

Learn more about Allison and her role here.